Agios Pharmaceuticals, Inc.

Royalty Pharma has built a unique and valuable business model within the biopharma sector, buying royalty revenue streams in exchange for capital to finance drug development and commercialization. And

A consumer genomics company might seem an odd fit for a biopharma company, but Regeneron Pharmaceuticals has some ideas for how to leverage the data and infrastructure of 23andMe in its drug discovery

A consumer genomics company might seem an odd fit for a biopharma company, but Regeneron Pharmaceuticals has some ideas for how to leverage the data and infrastructure of 23andMe in its drug discovery

A few months after restructuring to conserve cash and put primary focus on its lead candidate BDTX-1535 in first-line non-small cell lung cancer, Black Diamond Therapeutics found a lifeline in Servier